These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
282 related articles for article (PubMed ID: 29847489)
1. Nonalcoholic fatty liver disease-associated hepatocellular carcinoma in a hepatitis B virus-endemic area. Yoon CH; Jin YJ; Lee JW Eur J Gastroenterol Hepatol; 2018 Sep; 30(9):1090-1096. PubMed ID: 29847489 [TBL] [Abstract][Full Text] [Related]
2. Relative etiological role of prior hepatitis B virus infection and nonalcoholic fatty liver disease in the development of non-B non-C hepatocellular carcinoma in a hepatitis B-endemic area. Cho EJ; Kwack MS; Jang ES; You SJ; Lee JH; Kim YJ; Yoon JH; Lee HS Digestion; 2011; 84 Suppl 1():17-22. PubMed ID: 22156481 [TBL] [Abstract][Full Text] [Related]
3. Positive Hepatitis B Core Antibody Is Associated With Cirrhosis and Hepatocellular Carcinoma in Nonalcoholic Fatty Liver Disease. Chan TT; Chan WK; Wong GL; Chan AW; Nik Mustapha NR; Chan SL; Chong CC; Mahadeva S; Shu SS; Lai PB; Chan HL; Wong VW Am J Gastroenterol; 2020 Jun; 115(6):867-875. PubMed ID: 32149781 [TBL] [Abstract][Full Text] [Related]
4. Association of nonalcoholic fatty liver disease (NAFLD) with hepatocellular carcinoma (HCC) in the United States from 2004 to 2009. Younossi ZM; Otgonsuren M; Henry L; Venkatesan C; Mishra A; Erario M; Hunt S Hepatology; 2015 Dec; 62(6):1723-30. PubMed ID: 26274335 [TBL] [Abstract][Full Text] [Related]
5. Hepatocellular Carcinoma in the Setting of Non-cirrhotic Nonalcoholic Fatty Liver Disease and the Metabolic Syndrome: US Experience. Perumpail RB; Wong RJ; Ahmed A; Harrison SA Dig Dis Sci; 2015 Oct; 60(10):3142-8. PubMed ID: 26250831 [TBL] [Abstract][Full Text] [Related]
6. Clinical, Epidemiological and Histopathological Aspects in Patients with Hepatocellular Carcinoma Undergoing Liver Transplantation. Tunissiolli NM; Castanhole-Nunes MMU; Pavarino ÉC; da Silva RF; da Silva RCMA; Maria Goloni-Bertollo E Asian Pac J Cancer Prev; 2018 Oct; 19(10):2795-2802. PubMed ID: 30360608 [TBL] [Abstract][Full Text] [Related]
7. Differentiation of clinical patterns and survival outcomes of hepatocellular carcinoma on hepatitis B and nonalcoholic fatty liver disease. Lin BZ; Lin TJ; Lin CL; Liao LY; Chang TA; Lu BJ; Chen KY J Chin Med Assoc; 2021 Jun; 84(6):606-613. PubMed ID: 33871391 [TBL] [Abstract][Full Text] [Related]
8. [Study on the relationship between nonalcoholic fatty liver disease and hepatocellular carcinoma in patients with prior hepatitis B virus infection]. Chen L; Wang KF; Zhao Z; You QH; Wu YY; Sun J Zhonghua Gan Zang Bing Za Zhi; 2022 Jan; 30(1):52-56. PubMed ID: 35152669 [No Abstract] [Full Text] [Related]
9. Nonalcoholic fatty liver disease, metabolic risk factors, and hepatocellular carcinoma: an open question. Streba LA; Vere CC; Rogoveanu I; Streba CT World J Gastroenterol; 2015 Apr; 21(14):4103-10. PubMed ID: 25892859 [TBL] [Abstract][Full Text] [Related]
10. Application of hepatocellular carcinoma surveillance in a European setting. What can we learn from clinical practice? Edenvik P; Davidsdottir L; Oksanen A; Isaksson B; Hultcrantz R; Stål P Liver Int; 2015 Jul; 35(7):1862-71. PubMed ID: 25524812 [TBL] [Abstract][Full Text] [Related]
11. Survival after treatment with curative intent for hepatocellular carcinoma among patients with vs without non-alcoholic fatty liver disease. Wong CR; Njei B; Nguyen MH; Nguyen A; Lim JK Aliment Pharmacol Ther; 2017 Dec; 46(11-12):1061-1069. PubMed ID: 28960360 [TBL] [Abstract][Full Text] [Related]
12. Temporal trends, clinical patterns and outcomes of NAFLD-related HCC in patients undergoing liver resection over a 20-year period. Pais R; Fartoux L; Goumard C; Scatton O; Wendum D; Rosmorduc O; Ratziu V Aliment Pharmacol Ther; 2017 Nov; 46(9):856-863. PubMed ID: 28857208 [TBL] [Abstract][Full Text] [Related]
13. Clinical Patterns and Outcome of Hepatocellular Carcinoma in Patients with Nonalcoholic Fatty Liver Disease. Ahn SY; Kim SB; Song IH Can J Gastroenterol Hepatol; 2020; 2020():4873875. PubMed ID: 32566546 [TBL] [Abstract][Full Text] [Related]
14. [The Development of Hepatocellular Carcinoma in Non-alcoholic Fatty Liver Disease]. Kwon OS; Kim JH; Kim JH Korean J Gastroenterol; 2017 Jun; 69(6):348-352. PubMed ID: 28637103 [TBL] [Abstract][Full Text] [Related]
15. Serum alpha-fetoprotein may have a significant role in the surveillance of hepatocellular carcinoma in hepatitis B endemic areas. Sinn DH; Yi J; Choi MS; Kim YJ; Gwak GY; Lee JH; Koh KC; Paik SW; Yoo BC Hepatogastroenterology; 2015; 62(138):327-32. PubMed ID: 25916058 [TBL] [Abstract][Full Text] [Related]
16. Characteristics, aetiologies and trends of hepatocellular carcinoma in patients without cirrhosis: a United States multicentre study. Gawrieh S; Dakhoul L; Miller E; Scanga A; deLemos A; Kettler C; Burney H; Liu H; Abu-Sbeih H; Chalasani N; Wattacheril J Aliment Pharmacol Ther; 2019 Oct; 50(7):809-821. PubMed ID: 31475372 [TBL] [Abstract][Full Text] [Related]
17. Hepatitis B virus infection and the risk of liver disease progression in type 2 diabetic patients with potential nonalcoholic fatty liver disease: a retrospective, observational, cohort study in the United Kingdom Clinical Practice Research Datalink. Ferreira G; Stuurman AL; Horsmans Y; Cattaert T; Verstraeten T; Feng Y; Rosillon D; Guignard A Eur J Gastroenterol Hepatol; 2020 Jan; 32(1):101-109. PubMed ID: 31651649 [TBL] [Abstract][Full Text] [Related]
18. Association between hepatic steatosis and the development of hepatocellular carcinoma in patients with chronic hepatitis B. Lee YB; Ha Y; Chon YE; Kim MN; Lee JH; Park H; Kim KI; Kim SH; Rim KS; Hwang SG Clin Mol Hepatol; 2019 Mar; 25(1):52-64. PubMed ID: 30360031 [TBL] [Abstract][Full Text] [Related]